Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

39.03
Delayed Data
As of Jun 23
 +0.02 / +0.05%
Today’s Change
33.60
Today|||52-Week Range
50.40
+2.31%
Year-to-Date

Today’s Trading

Previous close39.01
Today’s open39.03
Day’s range38.67 - 39.29
Volume16,048,933
Average volume (3 months)5,901,553
Market cap$20.9B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-45.88%
Earnings growth (this year)+6.12%
Earnings growth (next 5 years)+7.03%
Revenue growth (last year)+17.44%
P/E ratio16.8
Price/Sales1.79
Price/Book1.88

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-2.06-2.12%
INCYIncyte Corp+0.65+0.48%
ALXNAlexion Pharmaceutic...-0.16-0.13%
ZTSZoetis Inc-0.73-1.15%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$1.17
Annual revenue (last year)$11.1B
Annual profit (last year)$480.0M
Net profit margin4.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts